
Krka Investor Relations Material
Latest events

Q1 2024
Krka

Q1 2025
16 May, 2025

H2 2024
10 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Krka d. d.
Access all reports
Krka, d. d., Novo mesto is a Slovenia-based international generic pharmaceutical company. The company focuses on the development, production, marketing, and sales of pharmaceutical products for human health, including prescription pharmaceuticals, self-medication products, and cosmetics. Additionally, Krka extends its product range to animal health products. With a presence in more than 70 countries, Krka has established production and distribution centers in key markets such as Russia, Poland, Croatia, and Germany, supporting its global distribution network. The company's commitment to quality and innovation has been instrumental in its expansion and ability to meet diverse health needs worldwide. The company is headquartered in Novo Mesto, Slovenia, and its shares are listed on the Warsaw Stock Exchange.
Key slides for Krka d. d.


Q4 2024
Krka d. d.


Q4 2024
Krka d. d.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
KRK
Country
🇸🇮 Slovenia